[1]戴高乐,罗万权,赵许亚,等.眼部Merkel细胞癌介入治疗1例[J].介入放射学杂志,2020,29(10):1060-1061.
 DAI Gaole,LUO Wanquan,ZHAO Xuya,et al.Successful interventional treatment of Merkel cell carcinoma located at the lateral canthus of left eye: report of one case[J].journal interventional radiology,2020,29(10):1060-1061.
点击复制

眼部Merkel细胞癌介入治疗1例()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
29
期数:
2020年10
页码:
1060-1061
栏目:
讲座
出版日期:
2020-10-25

文章信息/Info

Title:
Successful interventional treatment of Merkel cell carcinoma located at the lateral canthus of left eye: report of one case
作者:
戴高乐 罗万权 赵许亚 邓生华
Author(s):
DAI Gaole LUO Wanquan ZHAO Xuya DENG Shenghua.
Department of lnterventional Radiology, Guizhou Provincial Second People’s Hospital, Guiyang, Guizhou Province 550004, China
关键词:
【关键词】 癌Merkel细胞 抗肿瘤联合化疗方案 血管造影术 栓塞治疗性 动脉
文献标志码:
A
摘要:

参考文献/References:

[1] 王明建,李思源,赵鹏,等. Merkel细胞癌1例并文献回顾[J]. 外科(汉斯), 2018, 7: 61- 66.
[2] Jiang H, Shen G,Xu WC,et al. Efficacy of second- course intra- arterial chemo- therapy in children for advanced retinoblastoma recurrence after intra- arterial chemotherapy[J]. J Intervent Med, 2018, 1:98- 101.
[3] Tilling T, Moll I. Which are the cells of origin in Merkel cell carcinoma?[J]. J Skin Cancer, 2012, 2012:680410.
[4] Horvath KB, Pankovics P, Battyani Z, et al. A probable etiologicalrole of Merkel cell polyomavirus in the development of Merkel cell carcinoma[J]. Orv Hetil, 2013, 154: 102 - 112.
[5] 李 丽,朱学骏. Merkel细胞癌一例[J].中华皮肤科杂志,2000, 33:441.
[6] Tai P. A practical update of surgical management of Merkel cell carcinoma of the skin[J]. ISRN Surg, 2013, 2013: 850797.
[7] 王志伟,李伟人,刘 莉,等. 皮肤Merkel细胞癌171例临床及病理回顾分析[J]. 中华皮肤科杂志, 2018, 51:695- 698.
[8] Casciato DA, Territo MC. Manual of clinical oncology[M]. 6th ed. Philadelphia:Lippincott Williams & Wilkins, 2009:6- 7.
[9] 简 燚,陈易华,曾冬梅,等. 皮肤Merkel细胞癌7例临床病理分析[J]. 诊断病理学杂志, 2014, 21:69- 72.
[10] Barreira JV, Valejo Coelho MM, Ribeiro C, et al. Unknown primary Merkel cell carcinoma with cutaneous spread[J]. BMJ Case Rep, 2019, 12: e224834.

相似文献/References:

[1]周卫忠,刘 圣,杨正强,等.氰基丙烯酸酯胶栓塞原发性肝细胞癌合并重度肝动脉门静脉瘘12例疗效分析[J].介入放射学杂志,2013,(08):641.
 ZHOU Wei? zhong,LIU Sheng,YANG Zheng? qiang,et al. Transarterial embolization therapy with cyanoacrylate for severe arterioportal shunt associated with hepatocellular carcinoma[J].journal interventional radiology,2013,(10):641.
[2]郑家平,邵国良,罗 君,等. 索拉非尼治疗中晚期肝细胞癌安全性和预后因素分析[J].介入放射学杂志,2014,(03):222.
 ZHENG Jia? ping,SHAO Guo? liang,LUO Jun,et al. Sorafenib for the treatment of intermediate?蛳 advanced hepatocellular carcinomas: its safety and prognostic factors[J].journal interventional radiology,2014,(10):222.
[3]万豪光,许 伟,徐 浩,等. 经导管化疗栓塞联合经皮微波消融治疗中晚期肝癌64例的预后分析[J].介入放射学杂志,2014,(06):477.
 WAN Hao- guang,XU Wei,XU Hao,et al. Transcatheter arterial chemoembolization combined with percutaneous microwave ablation for the treatment of intermediate- advanced hepatocellular carcinoma: analysis of prognostic factors in 64 cases[J].journal interventional radiology,2014,(10):477.
[4]涂文辉,罗剑钧,刘清欣,等.原发性肝癌伴门静脉主干癌栓患者存活超5年1例并文献复习[J].介入放射学杂志,2015,(12):1101.
 TU Wen- hui,LUO Jian- jun,LIU Qing- xin,et al.Primary hepatocellular carcinoma associated with portal vein tumor thrombus: report of one case with survival over 5 years and review of literature [J].journal interventional radiology,2015,(10):1101.
[5]黄 芳,龚环宇,熊正平.雷替曲塞联合奥沙利铂TACE治疗BCLC B/C期肝细胞癌的安全性及疗效[J].介入放射学杂志,2018,27(01):76.
 HUANG Fang,GONG Huanyu,XIONG Zhengping.The safety and efficacy of raltitrexed combined with oxaliplatin in TACE treatment for BCLC B/C hepatocellular carcinomas[J].journal interventional radiology,2018,27(10):76.

备注/Memo

备注/Memo:
(收稿日期:2019- 09- 27)
(本文编辑:俞瑞纲)
更新日期/Last Update: 2020-10-19